Development of Resistance During Antimicrobial Therapy: A Review of Antibiotic Classes and Patient Characteristics in 173 Studies
Authors:
- Stephen C. PiscitelliSPStephen C. Piscitelli
- Larry H. DanzigerLDLarry H. Danziger
- 6 May 1995
- journal article
- review article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 15 (3) , 279-291
Abstract
The incidence of emergent resistance and clinical factors affecting its development were evaluated by retrospective review of 173 studies encompassing over 14,000 patients. Eight antibiotic classes and 225 individual treatment regimens were evaluated. Emergent resistance occurred among 4.0% of all organisms and 5.6% of all infections treated. It appeared to be significantly more frequent with penicillin and aminoglycoside monotherapy, with significantly lower rates associated with imipenem‐cilastatin, aztreonam, and combination therapy. Clinical failure also appeared to be significantly more likely to occur after emergence of resistance among organisms treated with fluoroquinolones or aminoglycosides. Infections associated with higher resistance rates were cystic fibrosis, osteomyelitis, and lower respiratory tract infections. Resistance was most common in patients in intensive care units or receiving mechanical ventilation. It was also significantly frequent among studies performed in university or teaching hospitals. Organisms associated with high resistance rates were Pseudomonas aeruginosa, Serratia, Enterobacter, and Acinetobacter sp. Factors such as infection type, underlying diseases, type of institution, and specific pathogens warrant consideration when examining emergent resistance.Keywords
This publication has 169 references indexed in Scilit:
- Randomised double-blind study of norfloxacin and cefadroxil in the treatment of acute pyelonephritisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990
- Intravenous and oral ciprofloxacin in the therapy of serious infectionsDiagnostic Microbiology and Infectious Disease, 1990
- Development of resistance during antibiotic therapyEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- Comparison of intravenous ciprofloxacin and mezlocillin in treatment of complicated urinary tract infectionEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- Ciprofloxacin in the treatment of urinary tract infection due to enterobacteriaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- Use of ciprofloxacin in the treatment ofPseudomonas aeruginosa infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- A multiclinic randomized study of the comparative efficacy, safety and tolerance of imipenem/cilastatin and moxalactamEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- Clinical experience with aztreonam in urinary and respiratory tract infectionsCurrent Medical Research and Opinion, 1984
- PIPERACILLIN IN SURGICAL INFECTIONS: A CLINICAL TRIALAnz Journal of Surgery, 1981
- Use of piperacillin, a semisynthetic penicillin, in the therapy of acute exacerbations of pulmonary disease in patients with cystic fibrosisThe Journal of Pediatrics, 1980